1. Home
  2. GERN vs CPK Comparison

GERN vs CPK Comparison

Compare GERN & CPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GERN
  • CPK
  • Stock Information
  • Founded
  • GERN 1990
  • CPK 1990
  • Country
  • GERN United States
  • CPK United States
  • Employees
  • GERN N/A
  • CPK N/A
  • Industry
  • GERN Biotechnology: Pharmaceutical Preparations
  • CPK Oil & Gas Production
  • Sector
  • GERN Health Care
  • CPK Utilities
  • Exchange
  • GERN Nasdaq
  • CPK Nasdaq
  • Market Cap
  • GERN 2.5B
  • CPK 2.9B
  • IPO Year
  • GERN 1996
  • CPK N/A
  • Fundamental
  • Price
  • GERN $3.93
  • CPK $125.07
  • Analyst Decision
  • GERN Strong Buy
  • CPK Hold
  • Analyst Count
  • GERN 10
  • CPK 4
  • Target Price
  • GERN $7.05
  • CPK $123.00
  • AVG Volume (30 Days)
  • GERN 6.7M
  • CPK 93.0K
  • Earning Date
  • GERN 11-07-2024
  • CPK 11-07-2024
  • Dividend Yield
  • GERN N/A
  • CPK 2.00%
  • EPS Growth
  • GERN N/A
  • CPK N/A
  • EPS
  • GERN N/A
  • CPK 4.91
  • Revenue
  • GERN $29,480,000.00
  • CPK $757,489,000.00
  • Revenue This Year
  • GERN $32,021.10
  • CPK $22.71
  • Revenue Next Year
  • GERN $298.14
  • CPK $6.95
  • P/E Ratio
  • GERN N/A
  • CPK $25.69
  • Revenue Growth
  • GERN 9199.68
  • CPK 12.63
  • 52 Week Low
  • GERN $1.64
  • CPK $98.25
  • 52 Week High
  • GERN $5.34
  • CPK $134.20
  • Technical
  • Relative Strength Index (RSI)
  • GERN 46.32
  • CPK 40.32
  • Support Level
  • GERN $3.75
  • CPK $125.00
  • Resistance Level
  • GERN $4.05
  • CPK $131.11
  • Average True Range (ATR)
  • GERN 0.16
  • CPK 2.40
  • MACD
  • GERN -0.01
  • CPK -0.89
  • Stochastic Oscillator
  • GERN 39.13
  • CPK 8.01

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

About CPK Chesapeake Utilities Corporation

Chesapeake Utilities Corp is a diversified energy delivery company that is engaged in natural gas transmission and distribution, electricity generation and distribution, propane gas distribution, mobile compressed natural gas utility services and solutions and other businesses. The company operates in two reportable segments, Regulated Energy and Unregulated Energy. The company's natural gas and electric distribution operations in Delaware, Maryland and Florida are subject to regulation by their respective PSC. Eastern Shore, its natural gas transmission subsidiary, is subject to regulation by the FERC and Peninsula Pipeline and Aspire Energy Express, its intrastate pipeline subsidiaries, are subject to regulation by the Florida PSC and Public Utilities Commission of Ohio, respectively.

Share on Social Networks: